Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
1. Donated Stem Cell Transplants Better than Self-transplants for Most Patients with AML (Posted: 07/23/2009) - Evidence from a meta-analysis of prospective clinical trials supports the use of donated (or allograft) stem cell transplants to treat most individuals with acute myeloid leukemia, according to the June 10, 2009, Journal of the American Medical Association.
![](https://webarchive.library.unt.edu/eot2008/20090826091219im_/http://www.cancer.gov/images/spacer.gif)
2. For Children with Leukemia, Radiation May Be Unnecessary (Posted: 07/23/2009) - Children with the most common form of leukemia can safely forego radiation therapy to prevent relapse if they are treated with chemotherapy regimens tailored to their individual needs, according to the June 25, 2009, New England Journal of Medicine.
![](https://webarchive.library.unt.edu/eot2008/20090826091219im_/http://www.cancer.gov/images/spacer.gif)
3. Radiofrequency Ablation Effective Against Barrett Esophagus (Posted: 07/23/2009) - In a randomized phase II trial, radiofrequency ablation led to high rates of eradication of the cell abnormalities associated with Barrett esophagus, according to the May 28, 2009, New England Journal of Medicine.
![](https://webarchive.library.unt.edu/eot2008/20090826091219im_/http://www.cancer.gov/images/spacer.gif)
4. Treatment Regimen Extends Survival for Women with Cervical Cancer (Posted: 06/29/2009) - Patients with locally advanced cervical cancer who received gemcitabine (Gemzar®) both as part of initial treatment and as part of therapy following primary treatment had improved survival compared with patients whose treatment did not include gemcitabine, according to findings presented at the 2009 ASCO meeting in Orlando.
![](https://webarchive.library.unt.edu/eot2008/20090826091219im_/http://www.cancer.gov/images/spacer.gif)
5. HPV Status Can Predict Outcome in Oropharyngeal Cancer (Posted: 06/19/2009) - Patients with advanced oropharyngeal cancer are more likely to survive if their tumors are HPV positive than if they are HPV negative, according to findings presented at the 2009 ASCO meeting in Orlando.
1 2 3 4 Next > |